1. Home
  2. RCKT vs CMPR Comparison

RCKT vs CMPR Comparison

Compare RCKT & CMPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • CMPR
  • Stock Information
  • Founded
  • RCKT 1999
  • CMPR 1994
  • Country
  • RCKT United States
  • CMPR Ireland
  • Employees
  • RCKT N/A
  • CMPR N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • CMPR Publishing
  • Sector
  • RCKT Health Care
  • CMPR Consumer Discretionary
  • Exchange
  • RCKT Nasdaq
  • CMPR Nasdaq
  • Market Cap
  • RCKT 1.9B
  • CMPR 2.5B
  • IPO Year
  • RCKT N/A
  • CMPR N/A
  • Fundamental
  • Price
  • RCKT $18.51
  • CMPR $90.76
  • Analyst Decision
  • RCKT Strong Buy
  • CMPR Strong Buy
  • Analyst Count
  • RCKT 9
  • CMPR 2
  • Target Price
  • RCKT $53.22
  • CMPR $119.50
  • AVG Volume (30 Days)
  • RCKT 655.8K
  • CMPR 158.0K
  • Earning Date
  • RCKT 08-05-2024
  • CMPR 10-23-2024
  • Dividend Yield
  • RCKT N/A
  • CMPR N/A
  • EPS Growth
  • RCKT N/A
  • CMPR N/A
  • EPS
  • RCKT N/A
  • CMPR 6.43
  • Revenue
  • RCKT N/A
  • CMPR $3,291,856,000.00
  • Revenue This Year
  • RCKT N/A
  • CMPR $7.63
  • Revenue Next Year
  • RCKT $300.20
  • CMPR $5.22
  • P/E Ratio
  • RCKT N/A
  • CMPR $14.12
  • Revenue Growth
  • RCKT N/A
  • CMPR 6.89
  • 52 Week Low
  • RCKT $15.27
  • CMPR $57.01
  • 52 Week High
  • RCKT $32.53
  • CMPR $104.92
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 42.14
  • CMPR 47.88
  • Support Level
  • RCKT $17.59
  • CMPR $94.04
  • Resistance Level
  • RCKT $19.30
  • CMPR $97.81
  • Average True Range (ATR)
  • RCKT 0.86
  • CMPR 3.93
  • MACD
  • RCKT 0.06
  • CMPR 0.19
  • Stochastic Oscillator
  • RCKT 34.59
  • CMPR 31.83

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About CMPR Cimpress plc (Ireland)

Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.

Share on Social Networks: